These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13854898)

  • 1. Studies on antiviral immunity using tissue culture methods. II. Obtaining cells resistant to poliomyelitis virus.
    SOLOVYOV VD; GULEVICH NE
    Acta Virol; 1960 Jul; 4():220-6. PubMed ID: 13854898
    [No Abstract]   [Full Text] [Related]  

  • 2. [Age factor of the sero-immunity of poliomyelitis viruses and ECHO virus type 9].
    SAUTHOFF R; HANSERT E; MITTELSTRASS HK
    Klin Wochenschr; 1958 Apr; 36(8):362-7. PubMed ID: 13550833
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of various methods of titration of virus-neutralizing antibodies to poliomyelitis virus in tissue culture].
    GINSBURG NN; KASYMOV KT; AL'TSHTEIN AD
    Vopr Virusol; 1960; 5():20-5. PubMed ID: 13850244
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytopathology of poliomyelitis virus in tissue culture; fluorescent antibody and tinctorial studies.
    BUCKLEY SM
    Am J Pathol; 1957; 33(4):691-707. PubMed ID: 13444457
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of type 2 poliomyelitis viruses. II. Antigenic differences relating to 18 type 2 strains.
    KAMITSUKA P; LENAHAN M; WENNER HA
    J Immunol; 1956 Oct; 77(4):220-31. PubMed ID: 13376893
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on the complement-fixing antibody response to poliovirus in patients with certain Coxsackie and ECHO virus infections.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL
    J Immunol; 1961 May; 86():552-60. PubMed ID: 13760855
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of susceptible and resistant cells to infection with poliomyelitis virus.
    KAPLAN AS
    Ann N Y Acad Sci; 1955 Sep; 61(4):830-8; discussion, 838-9. PubMed ID: 13340589
    [No Abstract]   [Full Text] [Related]  

  • 8. A specific virus-antibody flocculation reaction with poliomyelitis viruses.
    SMITH W; SHEFFIELD FW; LEE LH; CHURCHER G
    Lancet; 1956 May; 270(6925):710-3. PubMed ID: 13320852
    [No Abstract]   [Full Text] [Related]  

  • 9. [Herd immunity against poliomyelitis in children in the Moscow Region].
    Seĭbil' VB; Malyshkina LP; Tamazian GV; Konopleva TN; Uspenskaia ES
    Vopr Virusol; 2009; 54(6):13-8. PubMed ID: 20030276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavior of different strains of poliomyelitis virus in the complement fixation reaction. II. The sensitivity and specificity of antigens derived from various strains.
    SCHMIDT N; LENNETTE EH; HAGENS SJ; DENNIS J
    J Immunol; 1960 Feb; 84():160-70. PubMed ID: 14443079
    [No Abstract]   [Full Text] [Related]  

  • 11. [The kinetic reaction of sero-neutralization of poliomyelitis virus].
    LEPINE P; ROGER F; ROGER A
    Bull World Health Organ; 1959; 20(4):563-78. PubMed ID: 14415882
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isolation of infectious antigens from poliomyelitis virus preparations].
    AGOL VI; CHUMAKOVA MIa
    Vopr Virusol; 1961; 6():161-6. PubMed ID: 13681646
    [No Abstract]   [Full Text] [Related]  

  • 13. The behavior of different strains of poliomyelitis virus in the complement fixation reaction. III. Comparison of the potency of complement fixing antigens derived from different strains of poliomyelitis virus.
    SCHMIDT NJ; LENNETTE EH; DENNIS J; HAGENS SJ
    J Immunol; 1960 Jul; 85():67-71. PubMed ID: 14443080
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation of a non-infective antigen from preparations of poliomyelitis virus.
    AGOL VI; CHUMAKOVA MIa
    Probl Virol; 1961; 6():175-8. PubMed ID: 14036593
    [No Abstract]   [Full Text] [Related]  

  • 15. [Identification and antigenic typing of strains of poliomyelitis virus isolated in Japan].
    ENDO M; UCHIDA S; SAWAI Y; MAKINO M; SHIMIZU Y
    Jpn J Exp Med; 1960 Apr; 30():171-8. PubMed ID: 13820259
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell susceptibility to viruses.
    LURIA SE
    Ann N Y Acad Sci; 1955 Sep; 61(4):852-5. PubMed ID: 13340592
    [No Abstract]   [Full Text] [Related]  

  • 17. Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.
    Ghendon Y; Robertson SE
    Bull World Health Organ; 1994; 72(6):973-83. PubMed ID: 7867144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroneutralization of poliomyelitis viruses].
    DAGUET GL
    Ann Inst Pasteur (Paris); 1960 Jul; 99():103-13. PubMed ID: 13813691
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of poliomyelitis virus with combined antigenic characteristics of type I and type II.
    SPRUNT K; MOUNTAIN IM; REDMAN WM; ALEXANDER HE
    Virology; 1955 Jul; 1(2):236-49. PubMed ID: 13267990
    [No Abstract]   [Full Text] [Related]  

  • 20. The production of antibodies in cotton rats by living and killed poliomyelitis viruses.
    TOBIN JO
    Br J Exp Pathol; 1956 Apr; 37(2):161-7. PubMed ID: 13315891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.